First Approval:

About Saphnelo

SAPHNELO is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are on standard therapy.

SAPHNELO is not indicated for severe active lupus nephritis or severe active central nervous system lupus.

Are you ready to
find relief?

Our dedicated and experienced team of doctors can help you get back your quality of life, and are passionate about helping you invest in your long-term health.

Learn how we will help: